help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 36, No. 6 1259-1262
doi:10.1210/jcem-36-6-1259
Copyright © 1973 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FAGLIA, G.
Right arrow Articles by SPADA, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FAGLIA, G.
Right arrow Articles by SPADA, A.

Plasma Growth Hormone Response to Thyrotropin-Releasing Hormone in Patients with Active Acromegaly

G. FAGLIA, P. BKCK-PECCOZ, C. FERRARI, P. TRAVAGLINI, B. AMBROSI and A. SPADA

Second Medical Clinic, Endocrine Unit, University of Milan 20122 Milan, Italy

Out of 21 patients with active acromegaly, 12 increased plasma GH concentration after TRH injection (200 µg iv). No correlation was found between basal plasma GH levels, plasma GH response to hypoglycemia, arginine, oral glucose load and plasma GH response to TRH. The plasma GH peak often preceded that of TSH. One patient TSH unresponsive to TRH and 2 patients poorly responsive to TRH showed a rise in plasma GH. In 1 patient who increased both TSH and GH after TRH, the plasma TSH response was abolished by triiodothyronine administration, while that of plasma GH remained unchanged.

Since it has been demonstrated that a releasing hormone acts activating the adenylcyclase system after binding to specific cellular receptors, it is suggested that in some functioning pituitary tumors the activity of TRH in promoting GH release may be attributed to an alteration of the cellular membrane. Another speculative possibility is that TRH acts at a hypothalamic rather than at a pituitary locus.

Received November 20, 1972.




This article has been cited by other articles:


Home page
Hum ReprodHome page
Th. Kaltsas, N. Pontikides, G.E. Krassas, K. Seferiadis, D. Lolis, and I.E. Messinis
Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome
Hum. Reprod., November 1, 1999; 14(11): 2704 - 2708.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
G. Ramirez, W. M. O'Neill Jr, H. A. Bloomer, and W. Jubiz
Abnormalities in the Regulation of Growth Hormone in Chronic Renal Failure
Arch Intern Med, February 1, 1978; 138(2): 267 - 271.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
P. E. Cryer, W. H. Daughaday, W. S. Coxe, and L. V. Avioli
Diagnosis and Therapy of Acromegaly
Arch Intern Med, February 1, 1975; 135(2): 338 - 343.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. B. MIMS and J. E. BETHUNE
Acromegaly with Normal Fasting Growth Hormone Concentrations but Abnormal Growth Hormone Regulation
Ann Intern Med, December 1, 1974; 81(6): 781 - 784.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. BROWN, I. J. CHOPRA, J. S. CORNELL, J. M. HERSHMAN, D. H. SOLOMON, R. P. ULLER, and A. J. VAN HERLE
Thyroid Physiology in Health and Disease
Ann Intern Med, July 1, 1974; 81(1): 68 - 81.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1973 by The Endocrine Society